Study to Evaluate the Safety and Efficacy of KITE-439 in HLA-A*02:01+ Adults With Relapsed/Refractory HPV16+ Cancers
Gilead Sciences
Gilead Sciences
Genocea Biosciences, Inc.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Roger Williams Medical Center
University of Alabama at Birmingham
M.D. Anderson Cancer Center
Endocyte